Stock comparison
Side-by-side financials for FEMY and BSX. Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
BSX is larger
Market cap data is available for the leading company in this comparison.
Market value leader
BSX
Latest market capitalization comparison.
Revenue leader
BSX
FEMY: $2.29M vs BSX: $20.07B.
| Metric | FEMY | BSX |
|---|---|---|
| Market cap | - | $66.02 B |
| US-listed rank | - | #258 |
| Revenue (latest FY) | $2.29M | $20.07B |
| Net income (latest FY) | -$18.63M | - |
| Net margin | -812.3% | - |
| P/E (trailing FY) | - | - |
| SEC filings | 312 | 1,009 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
In their latest fiscal years, FEMASYS INC reported $2.29M in revenue while BOSTON SCIENTIFIC CORP reported $20.07B.
Full pages: FEMASYS INC and BOSTON SCIENTIFIC CORP, or browse the full rankings.